{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "USD", "regularMarketChangePercent": 6.875001, "regularMarketPrice": 1.71, "exchange": "NGM", "shortName": "Cognition Therapeutics, Inc.", "longName": "Cognition Therapeutics, Inc.", "messageBoardId": "finmb_39366358", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "PRE", "firstTradeDateMilliseconds": 1633699800000, "priceHint": 4, "earningsTimestampEnd": 1683230754, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.97, "epsForward": -1.19, "epsCurrentYear": -0.93, "priceEpsCurrentYear": -1.8387097, "sharesOutstanding": 29277200, "bookValue": 1.388, "fiftyDayAverage": 1.76326, "fiftyDayAverageChange": -0.05325997, "fiftyDayAverageChangePercent": -0.030205397, "twoHundredDayAverage": 1.94699, "twoHundredDayAverageChange": -0.23698997, "twoHundredDayAverageChangePercent": -0.12172121, "marketCap": 50064012, "forwardPE": -1.4369748, "priceToBook": 1.2319885, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-10-08", "averageAnalystRating": "1.5 - Strong Buy", "tradeable": false, "cryptoTradeable": false, "regularMarketChange": 0.110000014, "regularMarketTime": 1684180804, "regularMarketDayHigh": 1.7413, "regularMarketDayRange": "1.63 - 1.7413", "regularMarketDayLow": 1.63, "regularMarketVolume": 93123, "regularMarketPreviousClose": 1.6, "bid": 1.55, "ask": 1.91, "bidSize": 29, "askSize": 13, "fullExchangeName": "NasdaqGM", "financialCurrency": "USD", "regularMarketOpen": 1.69, "averageDailyVolume3Month": 66480, "averageDailyVolume10Day": 37810, "fiftyTwoWeekLowChange": 0.64, "fiftyTwoWeekLowChangePercent": 0.5981308, "fiftyTwoWeekRange": "1.07 - 6.269", "fiftyTwoWeekHighChange": -4.559, "fiftyTwoWeekHighChangePercent": -0.72722924, "fiftyTwoWeekLow": 1.07, "fiftyTwoWeekHigh": 6.269, "earningsTimestamp": 1683230754, "earningsTimestampStart": 1683230754, "displayName": "Cognition Therapeutics", "symbol": "CGTX"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "2500 Westchester Avenue", "city": "Purchase", "state": "NY", "zip": "10577", "country": "United States", "phone": "412 481 2210", "website": "https://www.cogrx.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, an orally delivered molecule modulator designed to penetrate the blood-brain barrier and bind selectively to the S2R complex for the treatment of Alzheimer's disease. The company is also developing COG0201 SHINE, a randomized double-blind and placebo-controlled for mild-to-moderate AD and is in phase II clinical trial. Its product pipeline also includes CT2168 for Synucleinopathies; and CT2074 for dry age-related macular degeneration. The company was incorporated in 2007 and is headquartered in Purchase, New York.", "fullTimeEmployees": 22, "companyOfficers": [{"maxAge": 1, "name": "Ms. Lisa  Ricciardi", "age": 62, "title": "CEO, Pres & Director", "yearBorn": 1960, "fiscalYear": 2022, "totalPay": {"raw": 794039, "fmt": "794.04k", "longFmt": "794,039"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 558405, "fmt": "558.4k", "longFmt": "558,405"}}, {"maxAge": 1, "name": "Dr. Anthony O. Caggiano M.D., Ph.D.", "title": "Chief Medical Officer and Head of R&D", "fiscalYear": 2022, "totalPay": {"raw": 578483, "fmt": "578.48k", "longFmt": "578,483"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. John Brendan Doyle", "age": 45, "title": "Chief Financial Officer", "yearBorn": 1977, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}